Table 2.
Group | Dominant fibroid diameter (cm; mean and range) | Dominant fibroid diameter reduction (%) | Dominant fibroid volume (cm3; mean and range) | Dominant fibroid volume reduction (%) | Uterine volume (cm3; mean and range) | Uterine volume reduction (%) | Fibroid infarction rate (mean and range) | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Baseline | Follow-up | Baseline | Follow-up | Baseline | Follow-up | Dominant | Overall | ||||
A (N = 12): >10 cm, <700 cm3 | 10.6 | 7.7 | 27 | 379 | 177 | 53 | 591 | 385 | 35 | 90% | 80% |
10–13 | 6.4–9.5 | 297–547 | 68–254 | 471–691 | 225–621 | 40–100% | 50–100% | ||||
B (N = 30): >10 cm, >700 cm3 | 12.6 | 9.4 | 25 | 723 | 353 | 51 | 1358 | 760 | 44 | 85% | 85% |
10–16 | 6.0–13.4 | 417–1265 | 79–1127 | 788–3037 | 134–1796 | 20–100% | 20–100% | ||||
C (N = 29): <10 cm, >700 cm3 | 7.9 | 6.5 | 18 | 199 | 131 | 34 | 1105 | 20 | 45 | 90% | 90% |
4.3–9.6 | 3.4–9.6 | 42–424 | 18–343 | 653–1855 | 58–1526 | 40–100% | 50–100% | ||||
All (N = 71) | 10.3 | 8 | 22 | 450 | 233 | 44 | 1125 | 639 | 43 | 86% | 87% |
4.3–16 | 3.4–13.4 | 42–1265 | 18–1127 | 471–3037 | 58–1796 | 20–100% | 20–100% |